RecruitingNCT07120880
Combined sleep and depression treatment for major depression with insomnia
About this title
Read the official source — NCT07120880Placebo comparisonAges 18–65France
Understand this study
Who could participate?
Listed age limits: 18 years to 65 years.
What will I do during this study?
You are randomly assigned to one of four combinations of active or sham (simulated) bright-light therapy and melatonin or placebo (an inactive comparison treatment). All groups also follow sleep-hygiene guidance and continue antidepressant treatment; depression symptoms are compared from baseline to week 8.
- Listed locations
- ParisSee all locations and recruitment
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateStarted: January 28, 2026
- Recruitment status
- Recruiting
- Enrollment listed in the registry
- 184
- Sponsor
- Assistance Publique - Hôpitaux de Paris
- Sponsor type
- Unknown or unclear
- Study type
- Procedure
- Intervention type
- PROCEDURE
- Study phase
- Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
- Locations
- France
- Age range
- From 18 Years to 65 Years
- Official registry ID
- NCT07120880
- Official title
Show the full official title
Efficacy of a Combination of Chronotherapeutics for the Treatment of Major Depressive Episode (MDE) With Insomnia: a Multicenter, Randomized, 2*2 Factorial, Double-blind, Placebo-controlled Trial
Recruitment & locations
RecruitingParis
A listed location does not confirm current availability.
Questions about this study
Who is behind this study?
The study sponsor is Assistance Publique - Hôpitaux de Paris.
Who can participate?
Listed age limits: 18 years to 65 years.
Is this study still recruiting?
The registry lists this study as recruiting.
